Alector, Inc. (ALEC) vs Lyell Immunopharma, Inc. (LYEL)
- Alector, Inc. ALEC 2.78 +9.88%
- Lyell Immunopharma, Inc. LYEL 17.11 +2.15%
Alector, Inc. and Lyell Immunopharma, Inc. are both Biotechnology companies. Alector, Inc. and Lyell Immunopharma, Inc. are of similar size ($411.8M and $376.7M). Lyell Immunopharma, Inc. has negative trailing earnings, so its P/E is not meaningful; Alector, Inc. trades at 7.1×. Alector, Inc. grew revenue faster over the last twelve months: 151.2% against −63.4%. Alector, Inc. has the higher net margin (23.9% vs −1,701,066.7%) and the higher return on invested capital (0.00% vs −1,070.8%). Across the 16 metrics below, Alector, Inc. leads on 12 and Lyell Immunopharma, Inc. on 4.
Valuation
Profitability
| Metric | ALEC | LYEL | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 68.51% |
| Operating margin | 20.16% | (1,783,580.00%) | 0.00% |
| Net margin | 23.87% | (1,701,066.67%) | 0.00% |
| Free cash flow margin | (86.31%) | (1,207,540.00%) | 0.00% |
| Return on equity | 47.52% | (97.79%) | (50.12%) |
| Return on assets | 16.53% | (74.85%) | (45.12%) |
| Return on invested capital | 0.00% | (1,070.83%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack